Acute Toxicity of Adjuvant Radiotherapy in Locally Advanced Differentiated Thyroid Carcinoma: First Results of the Multicenter Study Differentiated Thyroid Carcinoma (MSDS)

Strahlentherapie und Onkologie

Volumn 179, Issue 12, 2003, Pages 832-839

  Schuck, Andreas ^a   Biermann, Martin ^a   Pixberg, Michaela K ^a   Müller, Stefan B ^a   Heinecke, Achim ^a   Schober, Otmar ^a   Willich, Normann ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Differentiated thyroid carcinoma; Radiotherapy; Toxicity

Indexed keywords

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CERVICAL LYMPH NODE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; LARYNX; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; PHARYNX; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RADIATION BEAM; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; THYROID CARCINOMA; TOXICITY TESTING; TREATMENT INDICATION;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DOSE FRACTIONATION; ESOPHAGITIS; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; KARNOFSKY PERFORMANCE STATUS; LARYNGITIS; MIDDLE AGED; PHARYNGITIS; PROSPECTIVE STUDIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; SKIN; THYROID NEOPLASMS; TIME FACTORS;

EID: 0344236289     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1158-1     Document Type: Article

References (27)

1. Alexander C, Bader JB, Schaefer A, et al. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med 1998;39:1551-4.
2. Beer K, Zehnder D, Lussi A, et al. Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors. Strahlenther Onkol 2002;178:722-6.
3. Benker G, Olbricht T, Reinwein D, et al. Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy. Cancer 1990;65:1517-20.
4. Bieri S, Bentzen S, Huguenin P, et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Strahlenther Onkol 2003;179:390-5.
5. Biermann M, Schober O. GCP-compliant management of the Multicentric Study Differentiated Thyroid Carcinoma (MSDS) with a relational database under Oracle 8i. Inform Biom Epidemiol Med Biol 2002;33:441-59.
6. Dische S, Saunders M, Barrett A, et al. A randomised multicenter trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36.
7. Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996;77:172-80.
8. Gross M, Spahn U, Engenhart-Cabillic R. Precision of conventional simulation: which extent of accuracy is reachable in head and neck region? Strahlenther Onkol 2002;178:216-22.
9. Horiot J, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
10. Junginger T, Delbrück H, Dralle H, et al. Kurzgefasste interdisziplinäre Leitlinien 2002, 3. Aufl. Frankfurt/Main: Deutsche Krebsgesellschaft, 2002.
11. Kimmig B. Radiojodtherapie und perkutane Strahlentherapie der Struma maligna. Radiologe 1989;29:125-31.
12. Leisner B, Degelmann G, Dir W, et al. Behandlungsergebnisse bei Struma maligna 1960-1980. Dtsch Med Wochenschr 1982;107:1702-7.
13. Lennernäs B, Holmäng S, Hedelin H. High dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy. Strahlenther Onkol 2002;178:537-41.
14. Lerch H, Saur HB, Schober O. Bedeutung von Lymphknotenmetastasen beim differenzierten Schilddrüsenkarzinom. Nuklearmedizin 1995;34:203-6.
15. Lerch H, Schober O, Kuwert T, et al. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997;15:2067-75.
16. Lin JD, Tsang NM, Huang MJ, et al. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma. Jpn J Clin Oncol 1997;27:244-7.
17. Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer: preliminary report on acute toxicity. Radiother Oncol 1996;40:137-45.
18. Phlips P, Hanzen C, Andry G, et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 1993;19:399-404.
19. Polgar C, Fodor J, Orosz Z, et al. Electron and high dose rate brachytherapy boost in the conservative treatment of stage I-II breast cancer. First results of the randomized Budapest boost trial. Strahlenther Onkol 2002;178:615-23.
20. Sautter-Bihl ML, Raub J, Hetzel-Sesterheim M, et al. Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients. Strahlenther Onkol 2001;177:125-31.
21. Schober O. Radioiodine therapy of malignant thyroid diseases. Exp Clin Endocrinol 1994;102:55-66.
22. Schultze-Mosgau S, Grabenbauer G, Wehrhan F, et al. Histomorphological changes of vessel structure in head and neck vessels following preoperative or postoperative radiotherapy. Strahlenther Onkol 2002;178:299-306.
23. Seegenschmiedt MH, Sauer R. The systematics of acute and chronic radiation sequelae. Strahlenther Onkol 1993;169:83-95.
24. Seegenschmiedt MH, Sautter-Bihl ML, Willich N, et al. Perkutane Radiotherapie der Struma maligna. In: Leittinien in der Radioonkologie. Hrsg: Kommission "Qualitätssicherung in der Radioonkologie" (Vorsitz: R.-P. Müller), 1998.
25. Simpson WL, Panzarella T, Curruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988;14:1063-75.
26. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:1-12.
27. Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998;82:375-88.